DK0793646T3 - Aminoguanidincarboxylater til behandling af ikke-insulinkrævende diabetes mellitus - Google Patents

Aminoguanidincarboxylater til behandling af ikke-insulinkrævende diabetes mellitus

Info

Publication number
DK0793646T3
DK0793646T3 DK95939672T DK95939672T DK0793646T3 DK 0793646 T3 DK0793646 T3 DK 0793646T3 DK 95939672 T DK95939672 T DK 95939672T DK 95939672 T DK95939672 T DK 95939672T DK 0793646 T3 DK0793646 T3 DK 0793646T3
Authority
DK
Denmark
Prior art keywords
treatment
dependent diabetes
insulin
diabetes mellitus
aminoguanidine
Prior art date
Application number
DK95939672T
Other languages
Danish (da)
English (en)
Inventor
Heinrich J Schostarez
Steven P Tanis
Scott D Larsen
Valerie A Vaillancourt
Paul D May
John A Tucker
Martin D Meglasson
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/484,547 external-priority patent/US5994577A/en
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of DK0793646T3 publication Critical patent/DK0793646T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/16—Compounds containing any of the groups, e.g. aminoguanidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/16—Compounds containing any of the groups, e.g. aminoguanidine
    • C07C281/18—Compounds containing any of the groups, e.g. aminoguanidine the other nitrogen atom being further doubly-bound to a carbon atom, e.g. guanylhydrazones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK95939672T 1994-11-23 1995-11-13 Aminoguanidincarboxylater til behandling af ikke-insulinkrævende diabetes mellitus DK0793646T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34427494A 1994-11-23 1994-11-23
US08/484,547 US5994577A (en) 1994-11-23 1995-06-07 Aminoguanidine carboxylates for the treatment of non-insulin-dependent diabetes mellitus
PCT/US1995/014126 WO1996016031A1 (en) 1994-11-23 1995-11-13 Aminoguanidine carboxylates for the treatment of non-insulin-dependent diabetes mellitus

Publications (1)

Publication Number Publication Date
DK0793646T3 true DK0793646T3 (da) 2001-12-17

Family

ID=26993832

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95939672T DK0793646T3 (da) 1994-11-23 1995-11-13 Aminoguanidincarboxylater til behandling af ikke-insulinkrævende diabetes mellitus

Country Status (24)

Country Link
US (2) US6166080A (et)
EP (1) EP0793646B1 (et)
JP (1) JPH10509455A (et)
CN (2) CN1097580C (et)
AT (1) ATE205188T1 (et)
AU (1) AU705893B2 (et)
BR (1) BR9509741A (et)
CA (1) CA2202265A1 (et)
CZ (1) CZ288597B6 (et)
DE (2) DE793646T1 (et)
DK (1) DK0793646T3 (et)
EE (1) EE03392B1 (et)
ES (1) ES2163531T3 (et)
FI (1) FI972185A (et)
GE (1) GEP20002026B (et)
HU (1) HUT77133A (et)
MX (1) MX9703807A (et)
NO (1) NO308992B1 (et)
NZ (1) NZ297604A (et)
PL (1) PL184614B1 (et)
PT (1) PT793646E (et)
RU (1) RU2162462C2 (et)
SK (1) SK282357B6 (et)
WO (1) WO1996016031A1 (et)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9526331D0 (en) * 1995-12-22 1996-02-21 Smithkline Beecham Plc Novel method
US5955617A (en) 1996-05-21 1999-09-21 Pharmacia & Upjohn Company Aminoguanidine carboxylate lactams for the treatment of non-insulin-dependent diabetes mellitus
AU1725197A (en) * 1997-02-13 1998-09-08 Smithkline Beecham Plc Use of nitric oxid synthase inhibitors for the treatment of diabetes
US6001578A (en) * 1997-06-26 1999-12-14 Pharmacia & Upjohn Ab Methods of screening for modulators of uncoupling protein-2 (UCP-2) as potential treatments for obesity
SE9702457D0 (sv) * 1997-06-26 1997-06-26 Pharmacia & Upjohn Ab Screening
US6288124B1 (en) 1998-05-22 2001-09-11 Rima Kaddurah-Daouk Methods of inhibiting undesirable cell growth using an aminoguanidine compound
US6169115B1 (en) 1998-05-22 2001-01-02 Rima Kaddurah-Daouk Use of aminoguanidine analogs for the treatment of diseases of the nervous system
US6815421B1 (en) * 2001-03-22 2004-11-09 Osteopharm Inc. Polypeptides for use in ameliorating effects of aging in mammals
EP2283349A1 (en) * 2008-04-29 2011-02-16 Becton, Dickinson & Company Method and system for measuring a sample to determine the presence of and optionally treat a pathologic condition
WO2009144527A1 (en) * 2008-06-26 2009-12-03 Laboratorios Silanes, S.A. De C.V. A new metformin glycinate salt for blood glucose control
GB201300435D0 (en) * 2013-01-10 2013-02-27 Medical Res Council Benzylideneguanidine Derivatives and Therapeutic Use for the Treatment of Protein Misfolding Diseases
CN106661422B (zh) * 2015-04-23 2018-10-09 三菱瓦斯化学株式会社 气体发生剂以及使用该气体发生剂的发泡体的制造方法
US20170056352A1 (en) * 2015-08-25 2017-03-02 Rgenix, Inc. PHARMACEUTICALLY ACCEPTABLE SALTS OF beta-GUANIDINOPROPIONIC ACID WITH IMPROVED PROPERTIES AND USES THEREOF
WO2018160178A1 (en) 2017-03-01 2018-09-07 Rgenix, Inc. Pharmaceutically acceptable salts of b-guanidinopropionic acid with improved properties and uses thereof
CA3161341A1 (en) 2019-12-11 2021-06-17 Masoud Fakhr Tavazoie Methods of treating cancer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3412105A (en) 1966-01-05 1968-11-19 American Home Prod beta-aryl-n-guanidino-beta-alanines
US3943253A (en) * 1974-06-27 1976-03-09 Barer Sol J Guanido acids as fungicides
JPS54128523A (en) 1978-03-29 1979-10-05 Nippon Carbide Ind Co Ltd 3-guanidinoamino propionic acid and its preparation
US5130324A (en) * 1984-03-19 1992-07-14 The Rockefeller University 2-alkylidene-aminoguanidines and methods of use therefor
US5272165A (en) * 1984-03-19 1993-12-21 The Rockefeller University 2-alkylidene-aminoguanidines and methods of use therefor
US4758583A (en) * 1984-03-19 1988-07-19 The Rockefeller University Method and agents for inhibiting protein aging
IT1201511B (it) 1985-12-23 1989-02-02 Italfarmaco Spa Derivati citoprotettivi in patologie a base ischemica,loro preparazione e composizioni che li cntengono
US5059712A (en) 1989-09-13 1991-10-22 Cornell Research Foundation, Inc. Isolating aminoarginine and use to block nitric oxide formation in body
GB9200114D0 (en) 1992-01-04 1992-02-26 Scras Dual inhibitors of no synthase and cyclooxygenase

Also Published As

Publication number Publication date
FI972185A0 (fi) 1997-05-22
RU2162462C2 (ru) 2001-01-27
BR9509741A (pt) 1997-10-21
CZ288597B6 (cs) 2001-07-11
DE69522580D1 (de) 2001-10-11
CA2202265A1 (en) 1996-05-30
GEP20002026B (en) 2000-04-10
NZ297604A (en) 2000-07-28
SK282357B6 (sk) 2002-01-07
NO308992B1 (no) 2000-11-27
NO972346L (no) 1997-07-23
CN1097580C (zh) 2003-01-01
CN1164226A (zh) 1997-11-05
PT793646E (pt) 2002-03-28
JPH10509455A (ja) 1998-09-14
DE69522580T2 (de) 2002-10-10
ATE205188T1 (de) 2001-09-15
SK64097A3 (en) 1997-11-05
HUT77133A (hu) 1998-03-02
EP0793646A1 (en) 1997-09-10
EP0793646B1 (en) 2001-09-05
EE03392B1 (et) 2001-04-16
EE9700094A (et) 1997-10-15
NO972346D0 (no) 1997-05-22
US6329545B1 (en) 2001-12-11
MX9703807A (es) 1997-08-30
CN1377642A (zh) 2002-11-06
PL184614B1 (pl) 2002-11-29
AU705893B2 (en) 1999-06-03
FI972185A (fi) 1997-05-22
CZ136997A3 (cs) 1998-02-18
WO1996016031A1 (en) 1996-05-30
AU4279696A (en) 1996-06-17
US6166080A (en) 2000-12-26
ES2163531T3 (es) 2002-02-01
DE793646T1 (de) 1999-12-30
PL320361A1 (en) 1997-09-29

Similar Documents

Publication Publication Date Title
DK0793646T3 (da) Aminoguanidincarboxylater til behandling af ikke-insulinkrævende diabetes mellitus
DE69519207T2 (de) Kautschukzusammensetzung ohne Gehalt an carcinogenen Nitrosaminvorläufern, die als Verbindungsgummi geeignet ist
DK0797439T3 (da) Anvendelse af pramipexol som et neurobeskyttende middel
AU583651B2 (en) Novel nitromethylene derivatives
ATE131863T1 (de) Verwendung von halogenkohlenwasserstofflösungsmittel als reinigungsmittel
NO904208L (no) Inhibitorer som hemmer retrovirale proteaser.
HU9602645D0 (en) Pyridine-type thiazolidines
EP0330041A3 (de) Substituierte 1,2,4-Triazindione, Verfahren zu ihrer Herstellung und ihre Verwendung
DE69428546T2 (de) 3-acylaminobenzazepine
DE69510545D1 (de) Cck oder gastrin modulierende 5-heterocyclicyl-1,5-benzodiazepine
NO922811L (no) Beleggmateriale, samt fremgangsmaate ved fremstilling og anvendelse derav
SE9700706D0 (sv) Process for the preparation of benzothiazoline compounds
ES8601226A1 (es) Procedimiento para preparar fenoxialquilfosfinatos y fosfonatos
ES2074250T3 (es) Azocolorantes, procedimiento para su preparacion y su empleo.
MY126408A (en) Insecticidal oxadiazine compounds
DE59810106D1 (de) Substituierte 2,4-diamino-1,3,5-triazine
TH19444A (th) ชูโดเพพไทด์ชนิดใหม่ที่มีไทรฟลูออโรเมธิล-ซับสทิทิวเทด 2-อะซาไบไซโคลออดเทน